This right question about prevention: not whether it saves money, but whether it is worth the cost.
tinyurl.com/3ezrrvm4 @tuftscevr.bsky.social #health #prevention
Don't miss a chance to work with our renowned faculty! Applications for our 2025 CEA Registry Summer Fellowship close March 17th.
Learn more / apply today: cevr.tuftsmedicalcenter.org/news/2025-ce...
#internships #fellowship #healthecon
@pattysynnott.bsky.social @peterneumann11.bsky.social
Most viewed in the last 7 days from JAMA: This Medical News article discusses how the popularity of the antiobesity drugs #semaglutide and #tirzepatide may affect uptake of bariatric surgery.
https://ja.ma/4hLUcWf
Insurance type and employment sector significantly influence access to semaglutide for weight management, highlighting disparities in healthcare access for obesity treatment. doi.org/g82s48
Insurance Coverage, Type of Employment Shape Inequities in Access to Semaglutide @busph.bsky.social bu.edu/sph/news/artic…
#obesity #healthequity #publichealth #glp1 #semaglutide
#obesity #glp1 #healthequity #semaglutide
@astokespop.bsky.social @khemp.bsky.social
5/
Structural factors may impact access to novel GLP-1/GIP RAs.
Future research should assess variations among populations (ex. Medicare, Medicaid) & incorporate add’l sociodemographic characteristics (race, ethnicity, income)
4/
The top features were included in a multivariable logistic regression model to quantify associations.
Key factors identified included sex, region, plan type, antidepressant use, obesity class, and employer industry.
3/
We used Marketscan Commercial data through 2022 to identify a cohort of pts with obesity without diabetes.
A random forest model was used to pinpoint the most impactful predictors of use, applying SHapley Additive exPlanations (SHAP) values.
2/
What factors affect semaglutide prescription?
In our study in @JAMANetworkOpen, we found that sex, insurance plan type, and use of certain medications were associated with semaglutide initiation.
jamanetwork.com/journals/jaman…
1/
New data on baseline levels of treatment for obesity pre-GLP1s - TLDR - very low journals.lww.com/lww-medicalc...